Regeneron Pharmaceuticals (REGN)

Total Assets

$41.73B

Quarterly · Period ending: · USD

REGN logo

REGN Total Assets

Latest reported$41.73B
REGN Quarterly Total Assets ($25.40M → $41.73B)
High-resolution chart · PNG

REGN total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
41,730,000,000
40,868,800,000
40,558,700,000
40,169,400,000
38,219,200,000
37,545,200,000
37,759,400,000
37,441,900,000
36,086,800,000
34,369,600,000
33,080,200,000
32,163,300,000
30,657,500,000
30,059,900,000
29,214,500,000
27,677,800,000
27,205,800,000
26,348,700,000
25,434,800,000
23,671,500,000
21,485,900,000
17,772,200,000
17,163,300,000
16,084,000,000
14,428,700,000
15,757,500,000
14,805,200,000
13,939,300,000
13,173,600,000
12,854,800,000
11,734,500,000
10,805,613,000
9,951,980,000
9,372,696,000
8,764,286,000
8,701,215,000
8,106,373,000
7,817,365,000
6,973,466,000
6,828,019,000
6,204,906,000
5,904,460,000
5,609,132,000
5,182,915,000
4,526,970,000
4,198,573,000
3,871,827,000
3,739,419,000
3,456,078,000
3,260,396,000
2,951,013,000
2,640,415,000
2,378,259,000
2,275,998,000
2,080,490,000
1,660,615,000
1,457,500,000
1,350,159,000
1,323,583,000
983,031,000
1,046,864,000
1,074,293,000
1,089,432,000
942,433,000
790,641,000
787,156,000
741,202,000
742,192,000
742,345,000
681,421,000
670,038,000
825,891,000
851,225,000
930,876,000
936,258,000
573,096,000
597,858,000
601,431,000
585,090,000
355,186,000
378,332,000
402,089,000
423,501,000
419,275,000
446,948,000
470,292,000
473,108,000
472,685,000
488,174,000
506,178,000
479,555,000
500,501,000
395,547,000
430,441,000
391,574,000
418,592,000
440,451,000
471,865,000
495,397,000
318,613,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.